The Beginning...💡
- Eshwar and Anup met through Dr. David Issadore, whose laboratory combines microelectronics, microfluidics, and nanomaterials to create miniaturized platforms for the diagnosis of disease🔬
- They founded InnaMed while students at the University of Pennsylvania🎓
- The company was initially founded as a direct to consumer business aiming to make monitoring nutrition and wellness easier for the average person💊
Attending Y Combinator 🚀
- InnaMed was accepted to Y Combinator in Winter, 2017✔️
- The company was advised by Jared Friedman (co-founder of Scribd) and Paul Buchheit (creator of Gmail, co-founder of FriendFeed)👨🏫
- The company pivoted from a direct to consumer business model to a B2B model focused on chronic disease management and pharma industries↩️
- After Demo Day, InnaMed raised $1M for product development 💲
Licensing the Technology⚡
- InnaMed’s blood testing technology was first developed by Dr. Christopher Easley’s lab at Auburn University🧫
- Dr. Easley is funded by the NIH and NSF. He has 40+ publications and patents in microfluidics & bio-sensing and has supervised 20+ graduate students🥼
- Dr. Easley's lab initially developed blood testing technology for monitoring metabolism markers in animals to understand the biology of diabetes🧬
- An exclusive license between InnaMed and Auburn was finalized in 2018📝
- InnaMed has since improved the technology, filing additional patents, improving manufacturability and applying it to human blood samples🩸
Building the Team🧑🏽🤝🧑🏻
- After licensing tech, InnaMed hired a key inventor from Dr. Easley's lab👔
- InnaMed currently has 2 PhDs (from Auburn and Stanford), 2 scientists (from Merck and Adaptimmune), and a skilled mechanical engineer on the team🏢
- The company is contracting experienced engineers from Bresslergroup and Symbient PD to expedite product development efforts🔨
- InnaMed has amassed a team of pharma & diagnostics industry advisors and regularly consults with medical, regulatory and manufacturing experts🧰
- The company has wet/dry lab & offices in Philadelphia with 4 hardware prototype stations, 4 electrochemical test stations and 3 reagent stations🧪
Looking Forward👁️
- Funding from this round will be used for pilot manufacturing of HomeLab, patient usability studies and hiring additional engineers and scientists 📈
Raise Update - we have raised over $800k on Wefunder & $450k externally.
We are looking to keep the momentum going and hope to reach $1m on Wefunder in the next few weeks. Join us in enabling precision medicine by investing now.